Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

Br J Haematol. 2019 Jun;185(5):940-944. doi: 10.1111/bjh.15643. Epub 2018 Nov 8.
No abstract available

Keywords: allogeneic transplant; cytarabine; mantle cell lymphoma; prognosis; refractory.

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antimetabolites, Antineoplastic / pharmacology
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Cytarabine / pharmacology
  • Cytarabine / therapeutic use*
  • Disease Progression
  • Female
  • Humans
  • Lymphoma, Mantle-Cell / drug therapy*
  • Lymphoma, Mantle-Cell / mortality
  • Male
  • Middle Aged
  • Risk Factors
  • Survival Rate

Substances

  • Antimetabolites, Antineoplastic
  • Cytarabine